CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,113,000 | +165.6% | 218,143 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $419,000 | -74.6% | 218,143 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,650,000 | +171.4% | 436,286 | +123.9% | 0.00% | 0.0% |
| Q2 2018 | $608,000 | +54.3% | 194,822 | +18.0% | 0.00% | 0.0% |
| Q1 2018 | $394,000 | -20.4% | 165,060 | +30.3% | 0.00% | 0.0% |
| Q4 2017 | $495,000 | +55.2% | 126,696 | 0.0% | 0.00% | – |
| Q3 2017 | $319,000 | -8.9% | 126,696 | 0.0% | 0.00% | – |
| Q2 2017 | $350,000 | +171.3% | 126,696 | +14.6% | 0.00% | – |
| Q1 2016 | $129,000 | -52.4% | 110,543 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $271,000 | -18.4% | 110,543 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $332,000 | -27.4% | 110,543 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $457,000 | – | 110,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |